This patent provides the endothelial stem cell together with endothelial stem cell activatory genes as a pharmaceutical preparation for the stimulation of angiogenesis. This patent is useful for the treatment of ischemic disorders ranging from angina, to cerebral palsy, to peripheral vascular disease.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.